|
|||||
|
|
Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy |
|
| Authors: | A Diaz K Tan H He H Xu I Cueto AB Pavel JG Krueger E Guttman-Yassky |
| Affiliation: | 1. Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA;2. Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USA |
| Abstract: | |
| Keywords: | |
